A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

NCT02435121 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi